BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Day In Review: Sanofi-Aventis (France) (SASY.PA) In-Licenses Japanese Cancer Drug


7/5/2006 6:45:50 PM

July 5, 2006 -- Sanofi-Aventis will pay up to $360 million for a solid turmor cancer drug from Taiho Pharma; Abbott and AstraZeneca will co-develop a combination cholesterol drug; Tercica won summary judgments in a patent suit lodged against Insmed; Salix submitted information on Colazal; Cell Genesys pointed to a journal article with positive data on Gvax; Favrille said that favorable data on FavId was published in a journal; Pfizer touted data about anti-smoking drug Chantix; Aradigm received $27.5 million from Novo Nordisk for their inhaled insulin drug; TeGenero, a privately held German biotech, filed for bankruptcy after its lead compound caused grave side effects; Oculus Innovative Sciences filed for its IPO; and Medtronic won approval for InterStim II, a smaller stimulator for intractable overactive bladder. The Centient Biotech 200™ was down 23 points at 3652.60, a loss of .62%. More details...

Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES